4th Forum on Immunotherapy and Translational Immunology of Cancer (FIT Cancer IV)

Presented by the Spanish Group for Immuno-Biological Therapies in Cancer (GÉTICA) in collaboration with the Society for Immunotherapy of Cancer (SITC).

This program has already taken place.

FIT-Cancer IV was an educational program focused on facilitating the exchange of knowledge between immunologists and clinicians, to enable clinicians to integrate immunotherapies into their treatment strategy for cancer patients.

The official language of the program was Spanish. Gética is a Spanish non-profit, multi-disciplinary scientific society focused on research, education and the clinical implementation of cancer immunotherapies. To access the downloadable program from the meeting, please click here.

Now in it's fourth consecutive year of collaboration, SITC was pleased to announce the sponsorship of the following two speakers:

• Lorenzo Galuzzi, MD - Weill Cornell Medical College
• Robert Hawkins, MA, MB, BS, PhD, FRCP - University of Manchester

SITC also provided two (2) junior travel grants for the program - Details on how to apply can be found here.

SITC members also were eligible for discounted rates!

Click here for more information on the program.


#2018
#Biomarkers
#ClinicalTrials
#BoneCancers
#BrainCancers
#BreastCancers
#ColorectalCancer
#GastrointestinalCancers
#GenitourinaryCancers
#HeadandNeckCancers
#HematologicMalignancies
#LungCancers
#SkinCancers
#Article
#InPersonEvent
#Collaboration
#CollaborativeEvent
#Adverse Events
#Cellular Therapies
#ImmuneCheckpointInhibitors
#Toxicities
#Clinician
#Oncologist
#Researcher